Key facts
- It has raised $12.5M across 1 recorded rounds; the latest was Seed Round ($465K) in Jun 2025.
- Notable investors include Research Park at FAU, The 4100 Group.
- Instrumentum has filed 1 Form D with the SEC, most recently Jun 2025 ($465K sold to 4 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Instrumentum
Funding rounds
1 roundsAbout Instrumentum
Developer of an off-site surgical instrument sterilization technology intended for sterilization and lifecycle management purposes. The company utilizes a centralized, monitored sterilization process and scheduled instrument distribution, enabling hospitals and surgical centres to ensure consistent instrument availability, reduce surgery delays, and improve operational efficiency.
- Sector
- Healthcare
- HQ
- Boca Raton, FL, United States
- Founded
- 2022
- Employees
- 31
- Website
- instrumentum.com/
- Ownership
- Privately Held (backing)
Instrumentum doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Instrumentum shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Instrumentum in its N-PORT filings yet. We sweep new filings monthly.